74 related articles for article (PubMed ID: 21338240)
1. Myeloid antigen positivity in Turkish children with acute lymphoblastic leukemia lacks influence on prognosis.
Tanyeli A; Erbey F; Bayram I; Kömür M
Asian Pac J Cancer Prev; 2010; 11(6):1823-6. PubMed ID: 21338240
[TBL] [Abstract][Full Text] [Related]
2. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
Wiersma SR; Ortega J; Sobel E; Weinberg KI
N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients.
Unal S; Cetin M; Tuncer AM; Gümrük F; Yetgin S
Turk J Pediatr; 2008; 50(6):533-6. PubMed ID: 19227415
[TBL] [Abstract][Full Text] [Related]
4. Surface antigens analysis reveals significant expression of candidate targets for immunotherapy in adult acute lymphoid leukemia.
Piccaluga PP; Arpinati M; Candoni A; Laterza C; Paolini S; Gazzola A; Sabattini E; Visani G; Pileri SA
Leuk Lymphoma; 2011 Feb; 52(2):325-7. PubMed ID: 21077738
[No Abstract] [Full Text] [Related]
5. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
[TBL] [Abstract][Full Text] [Related]
6. Myeloid antigens in childhood lymphoblastic leukemia: clinical data point to regulation of CD66c distinct from other myeloid antigens.
Kalina T; Vaskova M; Mejstrikova E; Madzo J; Trka J; Stary J; Hrusak O
BMC Cancer; 2005 Apr; 5():38. PubMed ID: 15826304
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2 in combination to myeloid antigen expression in adult acute lymphoblastic leukemia and prognostic outcome.
Amirghofran Z; Daneshbod Y; Gholijani N
Oncol Res; 2009; 17(10):447-54. PubMed ID: 19725224
[TBL] [Abstract][Full Text] [Related]
8. Expression of CD15 as predictor of relapse in children with acute lymphoblastic leukemia of the pre-B type.
Lenkei R; Björk O; Ost A; Biberfeld P
Leuk Res; 1991; 15(4):189-94. PubMed ID: 1674292
[TBL] [Abstract][Full Text] [Related]
9. [Lymphoblastic lymphoma and acute lymphoblastic leukemia: a clinicopathologic, immunophenotypic and prognostic study in 153 Chinese patients].
Pan Y; Li GD; Liu WP; Zhang WY; Tang Y; Li FY
Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):810-5. PubMed ID: 20193455
[TBL] [Abstract][Full Text] [Related]
10. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance.
Koehler M; Schell MJ; Behm FG; Raimondi SC; Woodruff LS; Mirro J
Leukemia; 1991 Jan; 5(1):41-8. PubMed ID: 1999957
[TBL] [Abstract][Full Text] [Related]
11. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
[TBL] [Abstract][Full Text] [Related]
12. The influence of Bcl-2 and myeloid antigen expression on response to therapy in childhood acute lymphoblastic leukemia.
Amirghofran Z; Daneshbod Y; Gholijani N; Esmaeilbeig M
Arch Iran Med; 2011 May; 14(3):170-4. PubMed ID: 21529104
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry results at diagnosis and relapse in childhood acute lymphoblastic leukemia.
Bayram I; Erbey F; Kömür M; Kibar F; Tanyeli A
Asian Pac J Cancer Prev; 2010; 11(5):1321-4. PubMed ID: 21198285
[TBL] [Abstract][Full Text] [Related]
14. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate target antigens for antibody-based immunotherapy in childhood B-cell precursor ALL.
Gudowius S; Recker K; Laws HJ; Dirksen U; Tröger A; Wieczorek U; Furlan S; Göbel U; Hanenberg H
Klin Padiatr; 2006; 218(6):327-33. PubMed ID: 17080335
[TBL] [Abstract][Full Text] [Related]
16. Correlation of CD33 with poorer prognosis in childhood ALL implicates a potential of anti-CD33 frontline therapy.
Mejstríková E; Kalina T; Trka J; Starý J; Hrusák O
Leukemia; 2005 Jun; 19(6):1092-4. PubMed ID: 15830012
[No Abstract] [Full Text] [Related]
17. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
Li X; Du W; Liu W; Li X; Li H; Huang SA
APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric false myeloperoxidase-positive childhood B-lineage acute lymphoblastic leukemia.
Savaşan S; Buck S; Gadgeel M; Gabali A
Cytometry B Clin Cytom; 2018 May; 94(3):477-483. PubMed ID: 29244249
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
20. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study.
Yenerel MN; Atamer T; Yavuz AS; Kucukkaya R; Besisik S; Aktan M; Keskin H; Nalcaci M; Sargin D; Pekcelen Y; Dincol G
Ann Hematol; 2002 Sep; 81(9):498-503. PubMed ID: 12373349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
